The Ayush ministry on Wednesday allowed popular FMCG company Patanjali to sell its product Coronil as an immunity booster and not as a cure for COVID-19.
As per reports, the ministry also said that Patanjali cannot mention COVID-19 on the packaging of Coronil.
The ayurvedic drug had received licensing from the Uttarakhand government, where Patanjali headquarters are located, to be sold as an immunity booster.
At a press conference in Haridwar, Ramdev claimed the ministry has said that Patanjali did an “an appropriate job for Covid-19 management”.
“I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today,” he added.
Ramdev said the Union ministry had asked him to use the term “COVID management” in place of “COVID treatment” and he is following the instruction.
Patanjali ran into a controversy recently after it claimed that its new products Coronil’ and ‘Swasari’, its Ayurvedic medicines can treat COVID-19 patients within 14 days.
But soon after the product’s launch, the Ministry of Ayush asked the company to stop advertising the medicines until they were examined.